RT Journal Article
SR Electronic
T1 Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?
JF Breathe
JO Breathe
FD European Respiratory Society
SP 210110
DO 10.1183/20734735.0110-2021
VO 17
IS 4
A1 Quinn, Lauren A.
A1 Hirani, Sunaya H.
A1 Williams, Thomas C.
A1 Sinha, Ian P.
YR 2021
UL http://breathe.ersjournals.com/content/17/4/210110.abstract
AB It is uncertain whether immunoprophylaxis against RSV protects preterm babies with BPD against future respiratory problems. It is biologically plausible that it does, at least in some infants. https://bit.ly/3ikzwZD